Molar Potency Study of HM12470 in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

This is a phase 1 study to assess and compare molar potency of HM12470 and regular human insulin in healthy subjects.

Key facts

Study ID

NCT03330327

Run by

Hanmi Pharmaceutical Company Limited

People needed

56

Starts

2015-03-30

Expected to finish

2017-08-17

Last updated by the study team

2017-11-06

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Females must be non-pregnant and non-lactating
• Males must be surgically sterile or using an acceptable contraceptive method

You may not qualify if…

• Participation in an investigational study within 30 days prior to dosing
• Use of new prescription and non-prescription drugs within 3 weeks preceding the first dosing

Where it is running

• Hanmi Investigative Site — Chula Vista, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.